Tilray | TRLY - Market Capitalization


Tilray reported $4.27B in Market Capitalization this September of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Akebia Therapeutics USD 427M 297M Dec/2025
Alaunos Therapeutics USD 7M 2M Mar/2026
Aurora Cannabis CAD 193.82M 133.39M Mar/2026
Avita Medical AUD 105.47M 35.32M Dec/2025
Canopy Growth CAD 557.13M 99.33M Mar/2026
Cronos Group USD 1.03B 72.12M Jun/2026
Dianthus Therapeutics USD 4.58B 2.8B Mar/2026
Divis Laboratories Ltd INR 1.75T 167.78B Jun/2026
Ionis Pharmaceuticals USD 13.1B 642M Jun/2026
IQVIA Holdings USD 32.25B 3.62B Jun/2026
Organigram Holdings CAD 252.47M 59.69M Mar/2026
Organon & Co USD 3.56B 1.99B Jun/2026
Revvity USD 12.69B 2.75B Jun/2026
Tectonic Therapeutic USD 580M 190M Mar/2026
Viatris USD 18.49B 2.76B Jun/2026
Xeris Pharmaceuticals USD 1000M 303M Mar/2026
Zealand Pharma A/S 20.84B 12.51B Mar/2026